Rewiring Cancer Cell Death to Boost Pediatric Brain Tumor Immunotherapy

重新连接癌细胞死亡以促进儿童脑肿瘤免疫治疗

• 批准号: 475131
• 负责人: Workenhe Samuel Tekeste
• 金额: --
• 依托单位: University of Guelph
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-04-01 至 2025-04-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=475131&lang=en
• 关键词: *

The five-year survival of pediatric patients with high-grade gliomas is ~25% in children and glioma deaths account for the largest proportion of pediatric cancer deaths under the age of 4. The long-term goal of this study is to develop new and effective i

儿童和神经胶质瘤死亡的儿科患者的五年生存率约为25％，占4岁以下儿科癌症死亡的最大比例。这项研究的长期目标是开发新的有效的I